Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-09-30
DOI
10.1038/s41598-017-12637-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp)
- (2017) Alessandra Oliva et al. JOURNAL OF INFECTION
- mcr-1.2, a NewmcrVariant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512
- (2016) Vincenzo Di Pilato et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak
- (2016) Teysir Halaby et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals
- (2016) Jennifer H. Han et al. CLINICAL INFECTIOUS DISEASES
- Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods
- (2016) J. Osei Sekyere et al. JOURNAL OF APPLIED MICROBIOLOGY
- Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party
- (2016) A.P.R. Wilson et al. JOURNAL OF HOSPITAL INFECTION
- Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae
- (2016) Hong Du et al. LANCET INFECTIOUS DISEASES
- Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1
- (2016) Xu Yao et al. LANCET INFECTIOUS DISEASES
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- Loss of Hypermucoviscosity and Increased Fitness Cost in Colistin-Resistant Klebsiella pneumoniae Sequence Type 23 Strains
- (2015) Myung-Jin Choi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca
- (2015) Aurélie Jayol et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Unravelling of a mechanism of resistance to colistin inKlebsiella pneumoniaeusing atomic force microscopy
- (2015) C. Formosa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of anmgrBDeletion Mutant
- (2015) Tommaso Giani et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Tracking Nosocomial Klebsiella pneumoniae Infections and Outbreaks by Whole-Genome Analysis: Small-Scale Italian Scenario within a Single Hospital
- (2015) Raffaella Onori et al. JOURNAL OF CLINICAL MICROBIOLOGY
- MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin
- (2014) Antonio Cannatelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
- (2014) R. L. Nation et al. CLINICAL INFECTIOUS DISEASES
- Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014
- (2014) M. Monaco et al. Eurosurveillance
- Colistin resistance in Klebsiella pneumoniae
- (2014) Young-Mi Ah et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study
- (2014) Abiola Olumuyiwa Olaitan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
- (2014) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In VivoEmergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoPmgrBRegulator
- (2013) Antonio Cannatelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant Enterobacteriaceae
- (2013) M. J. Schwaber et al. CLINICAL INFECTIOUS DISEASES
- Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital
- (2013) Mohamed H. Al-Agamy et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2012) Zakuan Z. Deris et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing
- (2012) E. S. Snitkin et al. Science Translational Medicine
- PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients
- (2011) Amanda K. Miller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More